SRC and hepatocellular carcinoma: MiR-3064-5p exerted an antiangiogenic role by targeting the FOXA1/CD24/Src pathway in hepatocellular carcinoma (HCC) but oncogenic lncRNA MALAT1 acted as a ceRNA to sponge miR-3064-5p (15).